/Mckesson%20Corporation%20logo%20on%20building-by%20JHVEPhoto%20via%20iStock.jpg)
Irving, Texas-based McKesson Corporation (MCK) is a global healthcare services provider. Valued at $75.4 billion by market cap, it operates through U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and international segments. The company is expected to announce its Q1 earnings after the market closes on Wednesday, Aug. 7.
Ahead of the event, analysts expect McKesson to report a profit of $7.17 per share, down 1.4% from $7.27 per share reported in the year-ago quarter. The company has surpassed Wall Street’s EPS projections in three of the past four quarters while missing on one other occasion. MCK reported an EPS of $6.18 in the most recent quarter, missing the consensus estimates by 2.5%.